PHARMACODYNAMIC STUDY OF ORAL MIRTOSELECT IN PATIENTS WITH SUSPECTED HEPATIC DISEASE

• Conditions: Patients with operable liver metastases; MedDRA version: 8.1Level: LLTClassification code 10024700Term: Liver metastases

• Registration Number: EUCTR2006-004245-42-GB
• Lead Sponsor: niversity Hospitals of Leicester NHS Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-09-18
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

•Patients must be over 18 years of age.
•Patients must be of sound mind to give written informed consent
•Patients must have a high likelihood of a diagnosis of primary or secondary liver malignancy.
•All patients must have disease amenable to surgical resection.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Patients unfit for general anaesthesia.
•Patients with significant impairment of gastrointestinal function or absorption
•Patients unwilling or unable to comply with the protocol

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified